GT Biopharma Market Cap

GT Biopharma has a market cap or net worth of $5.78 million as of April 25, 2025. Its market cap has increased by 0.93% in one year.

Market Cap

5.78M

Enterprise Value

1.83M

1-Year Change

0.93%

Ranking

#5248

Market Cap Chart

Since October 18, 1983, GT Biopharma's market cap has decreased from $937.50M to $5.78M, a decrease of -99.38%. That is a compound annual growth rate of -11.53%.

Market Cap History

Date	Market Cap	% Change
Apr 25, 2025	5.78M	-15.14%
Dec 31, 2024	6.81M	-35.48%
Dec 29, 2023	10.56M	-63.37%
Dec 30, 2022	28.84M	-69.01%
Dec 31, 2021	93.05M	159.67%
Dec 31, 2020	35.83M	556.05%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	772.03B
UnitedHealth Group	386.16B
Johnson & Johnson	372.77B
AbbVie	319.07B
Novo Nordisk	276.96B
Abbott Laboratories	224.40B
AstraZeneca	215.41B
Novartis AG	210.89B

Market Cap Rankings